You are currently viewing a new version of our website. To view the old version click .

Strategies to Address Falling Vaccine Coverage and Vaccine Hesitancy

This special issue belongs to the section “Vaccines and Public Health“.

Special Issue Information

Dear Colleagues,

Vaccination is an important and effective public health intervention; however, vaccine coverage has been declining in many regions worldwide, increasing the risk of vaccine-preventable diseases. Vaccine hesitancy, which refers to the delay in accepting or refusing vaccines despite their availability, is influenced by numerous factors, including complacency, convenience, and confidence. Understanding and addressing these factors is crucial to reversing the falling vaccine coverage trend.

This Special Issue explores strategies and interventions to counteract falling vaccine coverage and vaccine hesitancy. It seeks to better understand the underlying causes of vaccine hesitancy, evaluate the effectiveness of different intervention strategies, and provide practical recommendations. In this Special Issue, we welcome original research articles and reviews that cover various aspects of vaccine coverage and hesitancy, including but not limited to the following:

  • Determinants of vaccine hesitancy;
  • Misinformation/inadequate communication;
  • Promoting vaccine acceptance and intervention effectiveness;
  • Community approaches to increasing vaccine uptake;
  • Innovations that support vaccination campaigns;

I look forward to receiving your contributions.

Dr. Georgios Marinos
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine hesitancy
  • vaccine coverage
  • public health
  • immunization
  • vaccination campaigns
  • misinformation
  • healthcare communication
  • policy interventions
  • community health
  • ethical considerations

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X